Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manfred Goos

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
AIDS (London, England)|January 25, 2002
Lymphocytes proliferate in blood and lymph nodes following interleukin-2 therapy in addition to highly active antiretroviral therapyUlrich R Hengge, Carsten Borchard, Stefan Esser, et al.
Melanoma Research|July 29, 2003
Immunoproteasome subunits LMP2 and LMP7 downregulation in primary malignant melanoma lesions: association with lack of spontaneous regressionJoachim Dissemond, Petra Goette, Janet Moers, et al.
Melanoma Research|June 5, 2003
Association of TAP1 downregulation in human primary melanoma lesions with lack of spontaneous regressionJoachim Dissemond, Petra Götte, Janet Mörs, et al.
The Journal of Investigative Dermatology|July 13, 2004
CpG motifs are efficient adjuvants for DNA cancer vaccinesAchim Schneeberger, Christine Wagner, Anja Zemann, et al.
The Journal of Investigative Dermatology|November 25, 2003
Activated neutrophils exert antitumor activity against human melanoma cells: reactive oxygen species-induced mechanisms and their modulation by granulocyte-macrophage-colony-stimulating factorJoachim Dissemond, Tatjana K Weimann, Lars A Schneider, et al.
Cancer Letters|January 21, 2004
Differential downregulation of endoplasmic reticulum-residing chaperones calnexin and calreticulin in human metastatic melanomaJoachim Dissemond, Michael Busch, Thomas Kothen, et al.
AIDS (London, England)|March 21, 2003
Double-blind, randomized, placebo-controlled phase III trial of oxymetholone for the treatment of HIV wastingUlrich R Hengge, Kristin Stocks, Heidi Wiehler, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|September 25, 2002
Mizolastine provides effective symptom relief in patients suffering from perennial allergic rhinitis: a double-blind, placebo-controlled study versus loratadineCharles Frèche, Francisque Leynadier, Friedrich Horak, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
AIDS (London, England)|January 25, 2002
Lymphocytes proliferate in blood and lymph nodes following interleukin-2 therapy in addition to highly active antiretroviral therapyUlrich R Hengge, Carsten Borchard, Stefan Esser, et al.
Melanoma Research|July 29, 2003
Immunoproteasome subunits LMP2 and LMP7 downregulation in primary malignant melanoma lesions: association with lack of spontaneous regressionJoachim Dissemond, Petra Goette, Janet Moers, et al.
Melanoma Research|June 5, 2003
Association of TAP1 downregulation in human primary melanoma lesions with lack of spontaneous regressionJoachim Dissemond, Petra Götte, Janet Mörs, et al.
The Journal of Investigative Dermatology|July 13, 2004
CpG motifs are efficient adjuvants for DNA cancer vaccinesAchim Schneeberger, Christine Wagner, Anja Zemann, et al.
The Journal of Investigative Dermatology|November 25, 2003
Activated neutrophils exert antitumor activity against human melanoma cells: reactive oxygen species-induced mechanisms and their modulation by granulocyte-macrophage-colony-stimulating factorJoachim Dissemond, Tatjana K Weimann, Lars A Schneider, et al.
Cancer Letters|January 21, 2004
Differential downregulation of endoplasmic reticulum-residing chaperones calnexin and calreticulin in human metastatic melanomaJoachim Dissemond, Michael Busch, Thomas Kothen, et al.
AIDS (London, England)|March 21, 2003
Double-blind, randomized, placebo-controlled phase III trial of oxymetholone for the treatment of HIV wastingUlrich R Hengge, Kristin Stocks, Heidi Wiehler, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|September 25, 2002
Mizolastine provides effective symptom relief in patients suffering from perennial allergic rhinitis: a double-blind, placebo-controlled study versus loratadineCharles Frèche, Francisque Leynadier, Friedrich Horak, et al.
Pageof 2